RxDoctor Payments Data

Glenda Pulliam

Gerontology · Millington, TNNPI 1952871055

Payments from drug & device makers

$513in general payments, 2019–2025

Across 20 payments — averaging $25.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$157
  • Amgen$104
  • Novo Nordisk$98
  • GSK$49
  • AbbVie$28
  • Dexcom, Inc.$18
  • plus $60 from 4 others

What the payments were for

  • Food & beverage$513100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$513 in reported general payments places this provider in the 55th percentile of 194 gerontology providers in Tennessee.

See all gerontology providers in Tennessee

Medicare billing

Part B allowed, 2024
$1,983
Medicare patients
29
Services billed
48

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide37$57,928
JardianceEmpagliflozin28$31,127
FarxigaDapagliflozin Propanediol19$18,331
EliquisApixaban12$11,069
Trelegy ElliptaFluticasone/Umeclidin/Vilanter13$10,250
Lantus SolostarInsulin Glargine,hum.Rec.Anlog18$2,257
Duloxetine Hcl38$1,169
Albuterol Sulfate HfaAlbuterol Sulfate46$1,137
Atorvastatin Calcium167$1,098
Omeprazole42$832
Quetiapine Fumarate19$815
Amlodipine Besylate218$810
Pantoprazole Sodium59$785
Levetiracetam12$710
Celecoxib24$612

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$98$57,92837 claims
AstraZenecaFarxiga$157$18,33119 claims
PfizerEliquis$15$11,06912 claims
GSKTrelegy Ellipta$49$10,25013 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 194 gerontology providers in Tennessee.

Other gerontology in Millington

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →